- Home
- SEAT vs NSPR Comparison
SEAT vs NSPR Comparison
Compare SEAT & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEAT
- NSPR
- Stock Information
- Founded
- SEAT 2001
- NSPR 2005
- Country
- SEAT United States
- NSPR United States
- Employees
- SEAT N/A
- NSPR N/A
- Industry
- SEAT Industrial Machinery/Components
- NSPR Medical/Dental Instruments
- Sector
- SEAT Industrials
- NSPR Health Care
- Exchange
- SEAT Nasdaq
- NSPR Nasdaq
- Market Cap
- SEAT 96.5M
- NSPR 99.7M
- IPO Year
- SEAT N/A
- NSPR N/A
- Fundamental
- Price
- SEAT $12.78
- NSPR $2.27
- Analyst Decision
- SEAT Hold
- NSPR Strong Buy
- Analyst Count
- SEAT 9
- NSPR 2
- Target Price
- SEAT $49.89
- NSPR $4.50
- AVG Volume (30 Days)
- SEAT 144.1K
- NSPR 68.6K
- Earning Date
- SEAT 11-06-2025
- NSPR 11-04-2025
- Dividend Yield
- SEAT N/A
- NSPR N/A
- EPS Growth
- SEAT N/A
- NSPR N/A
- EPS
- SEAT N/A
- NSPR N/A
- Revenue
- SEAT $694,007,000.00
- NSPR $7,066,000.00
- Revenue This Year
- SEAT N/A
- NSPR $7.48
- Revenue Next Year
- SEAT N/A
- NSPR $104.39
- P/E Ratio
- SEAT N/A
- NSPR N/A
- Revenue Growth
- SEAT N/A
- NSPR 7.60
- 52 Week Low
- SEAT $10.55
- NSPR $1.99
- 52 Week High
- SEAT $100.00
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- SEAT 45.08
- NSPR 38.14
- Support Level
- SEAT $12.58
- NSPR $2.21
- Resistance Level
- SEAT $13.87
- NSPR $2.37
- Average True Range (ATR)
- SEAT 1.10
- NSPR 0.10
- MACD
- SEAT 0.13
- NSPR -0.01
- Stochastic Oscillator
- SEAT 65.01
- NSPR 23.36
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.